Biotech FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review February 26, 2025
Biotech NMPA Accepts NDA and Grants Priority Review Designation to Innovent’s Ipilimumab Injection, China’s First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer February 24, 2025
Biotech Esphera SynBio’s Exosome Tech Featured on Advancements with Ted Danson on the Bloomberg cable and satellite network February 23, 2025
Biotech FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease February 22, 2025
Biotech Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight February 21, 2025
Biotech BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing February 20, 2025
Biotech Patented transdermal drug candidate from Vascarta may offer a convenient & cost-effective way to treat sickle cell disease February 19, 2025
Biotech Enzymatica AB Year-end report 2024: Strong performance in core markets – preparing for international growth February 18, 2025
Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 17, 2025